Population‐based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study

Jul 19, 2022Journal of cachexia, sarcopenia and muscle

Changes in Gut Bacteria Linked to Muscle Loss in a Large Population Study

AI simplified

Abstract

The study included 1417 participants, with a prevalence of 10.0%.

  • β-diversity of gut microbiota was significantly associated with prevalent sarcopenia, while α-diversity showed no significant association.
  • Participants with sarcopenia exhibited higher relative abundance of several specific gut bacteria, including Desulfovibrio piger and Clostridium symbiosum.
  • The abundance of six specific bacterial species was positively associated with the severity of sarcopenia.
  • A predictive model using gut microbiota data achieved an area under the receiver-operating characteristic curve (AUC) of 0.852 for distinguishing participants with sarcopenia.
  • Functional analysis indicated that certain metabolic pathways, such as phenylalanine biosynthesis, were depleted, while others related to staurosporine biosynthesis were enriched in individuals with sarcopenia.

AI simplified

Key numbers

141 of 1417 participants
Prevalence
Prevalence of in the study cohort.
0.852
AUC of Microbiota Classifier
Performance of the microbiota-based model for classification.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free